Yen‐Yang Chen

1.0k total citations
20 papers, 210 citations indexed

About

Yen‐Yang Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, Yen‐Yang Chen has authored 20 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 9 papers in Gastroenterology. Recurrent topics in Yen‐Yang Chen's work include Gastrointestinal Tumor Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (7 papers) and Gastrointestinal disorders and treatments (4 papers). Yen‐Yang Chen is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (7 papers) and Gastrointestinal disorders and treatments (4 papers). Yen‐Yang Chen collaborates with scholars based in Taiwan and United States. Yen‐Yang Chen's co-authors include Chi‐Tung Cheng, Chun‐Nan Yeh, Kun‐Chun Chiang, Ta‐Sen Yeh, Tsung-Wen Chen, Chun‐Yi Tsai, Jen‐Shi Chen, Yi-Yin Jan, Shang‐Yu Wang and Jeng‐Hwei Tseng and has published in prestigious journals such as Cancer, Journal of Investigative Dermatology and Medicine.

In The Last Decade

Yen‐Yang Chen

20 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yen‐Yang Chen Taiwan 9 126 81 79 58 26 20 210
Hiromichi Miyagaki Japan 10 94 0.7× 23 0.3× 161 2.0× 140 2.4× 45 1.7× 46 305
M. Thalhammer Austria 8 111 0.9× 15 0.2× 133 1.7× 38 0.7× 25 1.0× 26 238
Xiaoying Si China 14 127 1.0× 34 0.4× 202 2.6× 242 4.2× 25 1.0× 19 361
Jean-François Delattre France 9 77 0.6× 39 0.5× 149 1.9× 141 2.4× 28 1.1× 19 276
Toshiyuki Natsume Japan 9 150 1.2× 72 0.9× 166 2.1× 102 1.8× 36 1.4× 42 313
Gianni Mura Italy 10 191 1.5× 91 1.1× 90 1.1× 57 1.0× 14 0.5× 25 268
Hiroki Irie Japan 10 135 1.1× 53 0.7× 181 2.3× 121 2.1× 21 0.8× 60 304
Masaru Kimata Japan 10 156 1.2× 117 1.4× 191 2.4× 92 1.6× 45 1.7× 33 356
F. Espósito Spain 8 32 0.3× 10 0.1× 32 0.4× 95 1.6× 44 1.7× 24 216
Michael A. Choti United States 3 72 0.6× 39 0.5× 85 1.1× 103 1.8× 15 0.6× 4 166

Countries citing papers authored by Yen‐Yang Chen

Since Specialization
Citations

This map shows the geographic impact of Yen‐Yang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Yang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Yang Chen more than expected).

Fields of papers citing papers by Yen‐Yang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Yang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Yang Chen. The network helps show where Yen‐Yang Chen may publish in the future.

Co-authorship network of co-authors of Yen‐Yang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Yang Chen. A scholar is included among the top collaborators of Yen‐Yang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Yang Chen. Yen‐Yang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Hui‐Jen, Ming‐Huang Chen, Hsiu‐Po Wang, et al.. (2025). Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study. Cancer. 131(17). e70019–e70019. 1 indexed citations
2.
Chen, Yen‐Yang, et al.. (2025). Outcomes of Liposomal Irinotecan With 5‐FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance Status. Cancer Diagnosis & Prognosis. 5(2). 198–206. 1 indexed citations
3.
Chen, Yen‐Yang, et al.. (2022). Zone 0 thoracic endovascular aortic repair in high risk patients: A retrospective case series. Catheterization and Cardiovascular Interventions. 100(5). 787–794. 1 indexed citations
4.
Chu, Tian‐Huei, Yu‐Wei Chou, Sheng‐Lun Lin, et al.. (2021). A pilot study examining the relationship between environmental contaminants and colorectal cancer at a single medical institute in Taiwan. 40(4). 382–393. 1 indexed citations
5.
Liu, Yuyin, Yueh‐Wei Liu, Yen‐Yang Chen, et al.. (2021). The efficacy and toxicity of adjuvant S-1 schedule with 2-week administration followed by 1-week rest in gastric cancer patients. Journal of Gastrointestinal Oncology. 12(2). 297–306. 1 indexed citations
6.
7.
Chang, H. C., et al.. (2020). Isolated spontaneous superior mesenteric artery dissection: A rare cause of unexplained abdominal pain. Advances in digestive medicine. 7(4). 214–216. 2 indexed citations
8.
Liu, Keng-Hao, Chia‐Yen Hung, S. Hsueh, et al.. (2019). Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Journal of Clinical Medicine. 8(9). 1402–1402. 21 indexed citations
9.
Cheng, Chi‐Tung, Yen‐Yang Chen, Ren‐Chin Wu, et al.. (2018). MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients. Oncology Reports. 40(3). 1411–1421. 7 indexed citations
10.
Chen, Jen‐Shi, Chun‐Nan Yeh, Chi‐Tung Cheng, et al.. (2018). Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors. Oncology Letters. 16(3). 3070–3082. 3 indexed citations
11.
Yeh, Chun‐Nan, Shang‐Yu Wang, Yen‐Yang Chen, et al.. (2016). A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.. PubMed. 36(8). 4249–58. 21 indexed citations
12.
Liao, Chien‐Hung, Shang‐Yu Wang, Chun‐Yi Tsai, et al.. (2015). Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib. Medicine. 94(24). e1014–e1014. 11 indexed citations
13.
Cheng, Chi‐Tung, Shih‐Chiang Huang, Yen‐Yang Chen, et al.. (2015). Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. OncoTargets and Therapy. 8. 1899–1899. 8 indexed citations
14.
Chen, Yen‐Yang, Chun‐Nan Yeh, Chi‐Tung Cheng, et al.. (2014). Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study. Translational Oncology. 7(5). 620–625. 7 indexed citations
15.
Yeh, Chun‐Nan, Wen‐Hung Chung, Shih‐Chi Su, et al.. (2014). Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction. Journal of Investigative Dermatology. 134(11). 2768–2775. 20 indexed citations
16.
Cheng, Chi‐Tung, Chun‐Nan Yeh, Kun‐Chun Chiang, et al.. (2014). Clinical significance of pathological complete response in patients with metastatic gastrointestinal stromal tumors after imatinib mesylate treatment--lessons learned.. PubMed. 34(11). 6617–25. 9 indexed citations
17.
Yeh, Chun‐Nan, Chueh‐Chuan Yen, Yen‐Yang Chen, et al.. (2014). Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors. Oncotarget. 5(12). 4071–4086. 24 indexed citations
18.
Hsu, Chih-Chieh, Chiao‐En Wu, Jen‐Shi Chen, et al.. (2014). Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.. PubMed. 34(9). 5029–36. 17 indexed citations
19.
Yeh, Chun‐Nan, Yen‐Yang Chen, Jeng‐Hwei Tseng, et al.. (2011). Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan. Translational Oncology. 4(6). 328–335. 26 indexed citations
20.
Chiu, Yi‐Chun, Jui‐Wei Lin, Chi‐Sin Changchien, et al.. (2005). Clinicopathological characteristics and prognosis of patients with small intestinal stromal tumors.. PubMed. 104(12). 905–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromichi Miyagaki Breakdown of academic impact, for papers by M. Thalhammer Breakdown of academic impact, for papers by Xiaoying Si Breakdown of academic impact, for papers by Jean-François Delattre Breakdown of academic impact, for papers by Toshiyuki Natsume Breakdown of academic impact, for papers by Gianni Mura Breakdown of academic impact, for papers by Hiroki Irie Breakdown of academic impact, for papers by Masaru Kimata Breakdown of academic impact, for papers by F. Espósito Breakdown of academic impact, for papers by Michael A. Choti
Rankless by CCL
2026